Vault-13

SymBiosis Capital Partners, LLC

BENTONVILLE, AR · CIK 2006045 · 13F filing filed 2026-02-12

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$109.5m reported value
11positions
100.0%in top 10
—no comparable previous quarter

Holdings, Q4 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 EVOMMUNE INC COM SHS EVMN EVMN 1,280,778 $21.9m20.03% 20.03% First filing
2 VERASTEM INC COM NEW VSTM VSTM 2,000,000 $15.4m14.10% 14.10% First filing
3 AMPLITECH GROUP INC COM NEW AMPG AMPG 2,555,000 $13.2m12.09% 12.09% First filing
4 PRECIGEN INC COM PGEN PGEN 3,000,000 $12.5m11.45% 11.45% First filing
5 INVENTIVA SA ADS IVA IVA 2,600,000 $12.1m11.04% 11.04% First filing
6 NUVATION BIO INC COM CL A NUVB NUVB 1,250,000 $11.2m10.23% 10.23% First filing
7 RANI THERAPEUTICS HLDGS INC COM CL A RANI RANI 6,300,000 $8.5m7.77% 7.77% First filing
8 AARDVARK THERAPEUTICS INC COM AARD AARD 476,595 $6.3m5.71% 5.71% First filing
9 CLENE INC COM NEW CLNN CLNN 770,495 $4.5m4.13% 4.13% First filing
10 GENERATION BIO CO COM NEW COM NEW 665,000 $3.8m3.45% 3.45% First filing
11 SURROZEN INC *W EXP 08/01/203 *W EXP 08/01/203 150,000 $3.0k0.00% 0.00% First filing

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
GENERATION BIO CO 13G · filed 2025-11-14 6.3% no change 13G 2025-11-14